Literature DB >> 26876073

[Analysis of prognostic factors in patients with hepatocellular carcinoma (≤5 cm) underwent hepatectomy].

Weiqi Rong1, Weibo Yu, Jianxiong Wu, Fan Wu, Liming Wang, Fei Tian, Songlin An, Li Feng.   

Abstract

OBJECTIVE: To explore the clinical and pathological factors influencing the prognosis of patients with hepatocellular carcinoma (HCC)(≤5 cm) after hepatectomy.
METHODS: Two hundreds and nineteen cases with HCC(≤5 cm) undergoing hepatectomy in Cancer Hospital, Chinese Academy of Medical Sciences between December 2003 and July 2013 were collected. The alpha fetoprotein (AFP) level, tumor number, tumor size (diameter), liver cirrhosis, vascular invasion, capsular invasion, differentiation, surgical methods, resection margin, the way of treatments, the situation of recurrence and time to recurrence were analyzed. Log-rank test and the stepwise Cox proportional-hazards models were used to compare the prognosis, respectively.
RESULTS: The 1-, 3-, 5- and 10- year overall survival rates were 95.9%, 85.3%, 67.8% and 53.3% respectively in all patients.Single factor analysis indicated that vascular invasion, capsular invasion, tumor size, hepatic vascular occult, liver cirrhosis, tumor differentiation, AFP, the way of treatments, the situation of recurrence and time to recurrence can affect the prognosis significantly (all P<0.05). The multifactor analysis showed that AFP, tumor differentiation, liver cirrhosis, capsular invasion, tumor size and the situation of recurrence and time to recurrence were independent prognostic factors (all P<0.05).
CONCLUSION: The prognosis of patients with HCC(≤5 cm) underwent hepatectomy are affected by multi-factors, such as AFP, tumor differentiation, liver cirrhosis, capsular invasion, tumor size and the situation of recurrence and time to recurrence.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26876073     DOI: 10.3760/cma.j.issn.0529-5815.2016.02.003

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  1 in total

Review 1.  Management of centrally located hepatocellular carcinoma: Update 2016.

Authors:  Wei-Bo Yu; Andrew Rao; Victor Vu; Lily Xu; Jian-Yu Rao; Jian-Xiong Wu
Journal:  World J Hepatol       Date:  2017-05-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.